View Author
scopus: 36038178500

Morgan, G.

(Gareth Morgan)


patient myeloma study thalidomide dexamethasone lenalidomide treatment bortezomib response therapy combination trial blood phase rearrangement disease regimen survival result cancer month university grade chain group agent melphalan table factor leukemia department serum analysis hospital prednisone myeloma patients light novel agents ef ficacy cyclophosphamide novel cell transplantation number outcome diagnosis transplantation clonality cycle event marrow b-cell hematology relapse erasmus mc lymphoma immunoglobulin response rate palumbo level signi oncol effect randomized doxorubicin high-dose venou malignancy /refractory meeting thrombosis richardson neuropathy clonal thromboembolism toxicity criteria institute progression center protein




10 Most Recent Publications

Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study (Article)
Kumar, S. Lee, J.H. Leleu, X. Hulin, C. Klein, S.K. Sonneveld, P. Siegel, D. Bladé, J. Goldschmidt, H. Jagannath, S. Miguel, J.S. Orlowski, R.Z. Lahuerta, J.J. Palumbo, A. Sezer, O. Rajkumar, S.V. Durie, B.G.M. Morgan, G. Richardson, P.G. Crowley, J. Haessler, J. Feather, J. Hoering, A. Moreau, P.
2012-01-01
Genetic factors underlying the risk of bortezomib induced peripheral neuropathy in multiple myeloma patients (Article)
Corthals, S.L. Kuiper, R. Johnson, D.C. Sonneveld, P. Hajek, R. Holt, B. van der Magrangeas, F. Goldschmidt, H. Morgan, G. Avet-Loiseau, H.
2011-11-01
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN) (Article)
Palumbo, A. Bringhen, S. Zweegman, S. Terpos, E. Davies, F. Driessen, C. Gimsing, P. Gramatzki, M. Hajek, R. Johnsen, H.E. Da Costa, F.L. Sezer, O. Ludwig, H. Spencer, A. Beksaç, M. Morgan, G. Einsele, H. San Miguel, J. Sonneveld, P. Dimopoulos, M.A. Bladé, J. Mateos, M.V. Rosiñol, L. Boccadoro, M. Cavo, M. Lokhorst, H.M.
2011-10-27
Treatment of relapsed and refractory multiple myeloma in the era of novel agents (Article)
Donk, N.W.C.J. van de Lokhorst, H.M. Goldschmidt, H. Sonneveld, P. Johnsen, H.E. Bladé, J. San-Miguel, J-F. Palumbo, A. Dimopoulos, M.A. Cavo, M. Morgan, G. Einsele, H. Kropff, M. Schey, S. Avet-Loiseau, H. Ludwig, H.
2011-06-01
European Myeloma Network: The 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma (Article)
Engelhardt, M. Udi, J. Driessen, C. Patriarca, F. Gramatzki, M. Terpos, E. Sezer, O. Kropff, M. Straka, C. Johnsen, H.E. Waage, A. Boegsted, M. Kleber, M. Lokhorst, H.M. Hjek, R. Morgan, G. Boccadoro, M. Ludwig, H. Cavo, M. Polliack, A. Sonneveld, P. Einsele, H. Palumbo, A. Spencer, A. Rocci, A. Knop, S. Bruno, B. Bringhen, S. Pérez-Simn, J.A. Zweegman, S.
2010-11-01
Phase I/II clinical study of Tosedostat, an inhibitor of aminopeptidases, in patients with acute myeloid leukemia and myelodysplasia. (Article)
Löwenberg, B. Morgan, G. Bone, E. Flores, N. Richardson, A.F. Hooftman, L. Jenkins, C. Davies, F. Ossenkoppele, G.J. Burnett, A.K. Zachée, P. Dührsen, U. Dierickx, D. Müller-Tidow, C. Sonneveld, P. Krug, U.
2010-10-01
Current multiple myeloma treatment strategies with novel agents: A European perspective (Article)
Ludwig, H. Beksac, M. Goldschmidt, H. Harousseau, J-L. Hess, U. Ketterer, N. Kropff, M. Mendeleeva, L. Morgan, G. Palumbo, A. Plesner, T. San Miguel, J-F. Bladé, J. Shpilberg, O. Sondergeld, P. Sonneveld, P. Zweegman, S. Boccadoro, M. Cavenagh, J. Cavo, M. Dimopoulos, M.A. Drach, J. Einsele, H. Facon, T.
2010-02-05
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation (Article)
Palumbo, A. Sezer, O. Kumar, S. Hajek, R. Giralt, S. Bringhen, S. Anderson, K.C. Richardson, P.G. Cavo, M. Davies, F. Bladé, J. Einsele, H. Kyle, R. Dimopoulos, M.A. Spencer, A. Dispenzieri, A. Reiman, T. Shimizu, K. Lee, J.H. Attal, M. Boccadoro, M. Mateos, M.V. Chen, W. Miguel, J.S. Ludwig, H. Joshua, D. Chim, J. Hungria, V. Turesson, I. Durie, B.G.M. Lonial, S. Orlowski, R.Z. Moreau, P. Niesvizky, R. Morgan, G. Comenzo, R.L. Sonneveld, P.
2009-06-08
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders (Article)
Dispenzieri, A. Kyle, R. Dimopoulos, M.A. Comenzo, R.L. Einsele, H. Barlogie, B. Anderson, K.C. Gertz, M. Harousseau, J-L. Attal, M. Tosi, P. Sonneveld, P. Merlini, G. Boccadoro, M. Morgan, G. Richardson, P.G. Sezer, O. Mateos, M.V. Cavo, M. Joshua, D. Turesson, I. Chen, W. Shimizu, K. Miguel, J.S. Powles, R. Rajkumar, S.V. Durie, B.G.M. Ludwig, H. Hajek, R. Palumbo, A. Jagannath, S. Bladé, J. Lonial, S.
2009-01-01
Genetic associations with thalidomide mediated venous thrombotic events in myeloma identified using targeted genotyping (Article)
Johnson, D.C. Corthals, S.L. Jackson, G. Baris, D. Rajkumar, S.V. Davies, F. Durie, B.G.M. Crowley, J. Sonneveld, P. Ness, B. van Morgan, G. Ramos, C. Hoering, A. Cocks, K. Dickens, N.J. Haessler, J. Goldschmidt, H. Child, J.A. Bell, S.E.
2008-12-15
  • rss icon RSS Publication Feed
  • foaf icon FOAF Profile